Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001318

Director sold 4,500 shares at an average $64.71 ($291,192)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PERRY MICHAEL S Director 2022-01-03 Sale −2,628 $64.30 $168,980 87,372 D: show line 1 in the form
PERRY MICHAEL S Director 2022-01-03 Sale −1,600 $65.12 $104,192 85,772 D: show line 2 in the form
PERRY MICHAEL S Director 2022-01-03 Sale −272 $66.25 $18,020 85,500 D: show line 3 in the form
Open-market sales · 4,500 sh · avg $64.71 · $291,192
Loading xslF345X03/doc4.xml…